09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3512 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
(51) (97) (54)<br />
A61K 49/00 (2006.01) EP 2<strong>09</strong>4310 * STABILITY AND IN THE SCREENING OF FACTORS INFLUENCING CARTILAGE<br />
PRODUCTION<br />
MARKER GENES FOR USE IN THE IDENTIFICATION OF CHONDROCYTE PHENOTYPIC<br />
A61K 49/00 (2006.01) EP 2<strong>09</strong>4640 * ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE ACTIVATORS OR MODULATORS OF<br />
THE PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR (PPAR).<br />
A61K 51/04 (2006.01) EP 2074135 * SILICON DERIVATIVES FOR PET IMAGING<br />
A61K 51/04 (2006.01) EP 2086924 * [F-18]-LABELED L-GLUTAMIC ACID, [F-18]-LABELED L-GLUTAMINE, DERIVATIVES<br />
THEREOF AND USE THEREOF AND PROCESSES FOR THEIR PREPARATION<br />
A61K 51/08 (2006.01) EP 2074135 * SILICON DERIVATIVES FOR PET IMAGING<br />
A61K 51/10 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
A61K 51/10 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
A61K 51/10 (2006.01) EP 2<strong>09</strong>2058 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
A61K 8/04 (2006.01) EP 2086497 * COSMETIC OR DERMATOLOGICAL FORMULATION WITH MANDELIC ACID AND<br />
AUXILIARIES<br />
A61K 8/04 (2006.01) EP 2<strong>09</strong>1501 * NOVEL COMPOSITION<br />
A61K 8/18 (2006.01) EP 2<strong>09</strong>9414 * HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING<br />
A61K 8/25 (2006.01) EP 2<strong>09</strong>1501 * NOVEL COMPOSITION<br />
A61K 8/26 (2006.01) EP 2086497 * COSMETIC OR DERMATOLOGICAL FORMULATION WITH MANDELIC ACID AND<br />
AUXILIARIES<br />
A61K 8/28 (2006.01) EP 2086497 * COSMETIC OR DERMATOLOGICAL FORMULATION WITH MANDELIC ACID AND<br />
AUXILIARIES<br />
A61K 8/365 (2006.01) EP 2086497 * COSMETIC OR DERMATOLOGICAL FORMULATION WITH MANDELIC ACID AND<br />
AUXILIARIES<br />
A61K 8/44 (2006.01) EP 2086497 * COSMETIC OR DERMATOLOGICAL FORMULATION WITH MANDELIC ACID AND<br />
AUXILIARIES<br />
A61K 8/44 (2006.01) EP 2086499 * 5- METHYL-CYCLOHEXANECARBONYL-D-ALANINE METHYL ESTER AND ONE OR MORE<br />
SKIN MOISTURISING AGENTS<br />
COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH A CONTENT OF 2-ISOPROPYL-<br />
A61K 8/44 (2006.01) EP 2086500 * (R)-2-Ý((1R, 2S, 5R)-2-ISOPROPYL-5-METHYL-CYCLOHEXANECARBONYL)-AMINO¨-<br />
PROPIONATE AND ONE OR MORE LIGHT PROTECTIVE FILTER SUBSTANCES<br />
COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH COMBINATIONS OF METHYL<br />
A61K 8/49 (2006.01) EP 2100588 * PROPHYLACTIC OR THERAPEUTIC AGENT FOR ALOPECIA<br />
A61K 8/73 (2006.01) EP 2<strong>09</strong>1501 * NOVEL COMPOSITION<br />
A61K 8/81 (2006.01) EP 2<strong>09</strong>1501 * NOVEL COMPOSITION<br />
A61K 8/86 (2006.01) EP 2086497 * COSMETIC OR DERMATOLOGICAL FORMULATION WITH MANDELIC ACID AND<br />
AUXILIARIES<br />
A61K 8/92 (2006.01) EP 2088995 * STICK LIP BALM<br />
A61K 9/00 (2006.01) EP 2086504 * DICLOFENAC GEL<br />
A61K 9/00 (2006.01) EP 2088997 * LIQUID ANTI-RABIES ANTIBODY FORMULATIONS<br />
A61K 9/00 (2006.01) EP 2088999 * PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT WHICH<br />
NEUTRALIZES AND/OR BINDS GASTRIC ACID, SUCH AS AN ALGINIC ACID DERIVATIVE<br />
A61K 9/00 (2006.01) EP 2089060 * LIQUID PREPARATION COMPRISING A COMPLEX OF PIMOBENDAN AND<br />
CYCLODEXTRIN<br />
A61K 9/00 (2006.01) EP 2<strong>09</strong>4236 * GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS<br />
A61K 9/00 (2006.01) EP 2<strong>09</strong>4247 * STABLE POLYPEPTIDE FORMULATIONS<br />
A61K 9/00 (2006.01) EP 2<strong>09</strong>4729 * ABETA ANTIBODY PARENTERAL FORMULATION<br />
A61K 9/00 (2006.01) EP 2<strong>09</strong>7062 * WIDE-AREA PARASYSTEMIC TREATMENT OF SKIN RELATED CONDITIONS<br />
A61K 9/00 (2006.01) EP 2<strong>09</strong>7063 * HELICALLY-SHAPED DRUG DELIVERY SYSTEM<br />
A61K 9/02 (2006.01) EP 2<strong>09</strong>4270 * DELIVERY SYSTEM FOR RISPERIDONE<br />
A61K 9/02 (2006.01) EP 2<strong>09</strong>4348 * DELIVERY SYSTEM FOR A NON-STEROIDAL NON-IONIZED HYDROPHILIC DRUG<br />
A61K 9/06 (2006.01) EP 2086504 * DICLOFENAC GEL<br />
A61K 9/10 (2006.01) EP 2088999 * PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT WHICH<br />
NEUTRALIZES AND/OR BINDS GASTRIC ACID, SUCH AS AN ALGINIC ACID DERIVATIVE<br />
A61K 9/12 (2006.01) EP 2<strong>09</strong>2941 Drug releasing coatings for medical devices<br />
A61K 9/14 (2006.01) EP 1935415 Treatment of androgen-deprivation induced osteoporosis<br />
A61K 9/14 (2006.01) EP 20865<strong>09</strong> * ESCITALOPRAM AND SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br />
A61K 9/14 (2006.01) EP 2086511 * POLYMER-BASED ANTIMICROBIAL AGENTS, METHODS OF MAKING SAID AGENTS, AND<br />
PRODUCTS AND APPLICATIONS USING SAID AGENTS<br />
A61K 9/14 (2006.01) EP 2087883 Stabilised supersaturated solid solutions of steroidal drugs<br />
A61K 9/14 (2006.01) EP 2<strong>09</strong>4275 * METHODS AND FORMULATIONS FOR IMPROVED BIOAVAILABILITY OF<br />
ANTIPROGESTINS<br />
A61K 9/16 (2006.01) EP 2087883 Stabilised supersaturated solid solutions of steroidal drugs<br />
A61K 9/16 (2006.01) EP 2<strong>09</strong>4246 * SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME<br />
A61K 9/19 (2006.01) EP 2<strong>09</strong>4247 * STABLE POLYPEPTIDE FORMULATIONS<br />
A61K 9/19 (2006.01) EP 2<strong>09</strong>7068 * FORMULATIONS OF PEG-INTERFERON ALPHA CONJUGATES<br />
A61K 9/20 (2006.01) EP 20865<strong>09</strong> * ESCITALOPRAM AND SOLID PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br />
A61K 9/20 (2006.01) EP 2088999 * PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT WHICH<br />
NEUTRALIZES AND/OR BINDS GASTRIC ACID, SUCH AS AN ALGINIC ACID DERIVATIVE<br />
ISSN 1331-2030
Change language